Evidence map›Paper›PMID 20441784›Full record

ArticlePeptides2010

NMR solution structure of poliovirus uridylyated peptide linked to the genome (VPgpU).

Catherine H Schein, Numan Oezguen, Gerbrand J van der Heden van Noort, Dmitri V Filippov, Aniko Paul, Eric Kumar, Werner Braun

Open access · greenAbstract readComparative Study
In one paragraph

Article in Peptides, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Allosteric inhibitors of Coxsackie virus A24 RNA polymerase.Bioorganic & medicinal chemistry · 2016
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Catherine H ScheinComputational Biology, Sealy Center for Structural Biology and Molecular Biophysics, Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX 77555-0857, USA. chschein@utmb.edu
Numan Oezguen
Gerbrand J van der Heden van Noort
Dmitri V Filippov
Aniko Paul
Eric Kumar
Werner Braun
The University of Texas Medical Branch at Galveston · USStony Brook University · US

Funding

POLIOVIRUS--MOLECULAR BIOLOGY AND SURFACE STRUCTURER37AI015122 · NIAID · STATE UNIVERSITY NEW YORK STONY BROOK · PI WIMMER, ECKARD · 1988 to 2007
$3.8M
Computational tools for T- and B-cell epitope predictionR01AI064913 · NIAID · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI BRAUN, WERNER A · 2005 to 2010
$1.6M
NIAID NIH HHS R01 AI064913NIAID NIH HHS R37 AI015122NIAID NIH HHS R37AI015122
6 · The paper itself

Abstract

Picornaviruses have a 22-24 amino acid peptide, VPg, bound covalently at the 5' end of their RNA, that is essential for replication. VPgs are uridylylated at a conserved tyrosine to form VPgpU, the primer of RNA synthesis by the viral polymerase. This first complete structure for any uridylylated VPg, of poliovirus type 1 (PV1)-VPgpU, shows that conserved amino acids in VPg stabilize the bound UMP, with the uridine atoms involved in base pairing and chain elongation projected outward. Comparing this structure to PV1-VPg and partial structures of VPg/VPgpU from other picornaviruses suggests that enteroviral polymerases require a more stable VPg structure than does the distantly related aphthovirus, foot and mouth disease virus (FMDV). The glutamine residue at the C-terminus of PV1-VPgpU lies in back of the uridine base and may stabilize its position during chain elongation and/or contribute to base specificity. Under in vivo-like conditions with the authentic cre(2C) hairpin RNA and Mg(2+), 5-methylUTP cannot compete with UTP for VPg uridylyation in an in vitro uridylyation assay, but both nucleotides are equally incorporated by PV1-polymerase with Mn(2+) and a poly-A RNA template. This indicates the 5 position is recognized under in vivo conditions. The compact VPgpU structure docks within the active site cavity of the PV-polymerase, close to the position seen for the fragment of FMDV-VPgpU with its polymerase. This structure could aid in design of novel enterovirus inhibitors, and stabilization upon uridylylation may also be pertinent for post-translational uridylylation reactions that underlie other biological processes.

Indexed as

Amino Acid SequenceAntiviral AgentsBinding, CompetitiveDrug DesignHeLa CellsHumansModels, MolecularMolecular Sequence DataNuclear Magnetic Resonance, BiomolecularPeptidesPoliovirusProtein ConformationProtein Processing, Post-TranslationalProtein StabilityRNA-Dependent RNA PolymeraseSequence AlignmentAntiviral AgentsPeptidespolymerase 3Dpol, poliovirusRNA-Dependent RNA PolymeraseUracil NucleotidesUridine MonophosphateUridine TriphosphateViral ProteinsVPg protein, poliovirus

Identifiers

PMID20441784
PMCPMC2905501
OpenAlexW2020538778

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.